Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.67 USD | +1.14% | -1.84% | -61.16% |
May. 30 | SAB Biotherapeutics, Inc. Announces Change of Chief Financial Officer | CI |
May. 21 | FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics | CI |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- Other languages